ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

Future Directions in Lung Cancer Treatment

Haleigh Behrman
on: January 07, 2025In: Global Initiatives, Meeting News, Society News
Future Directions in Lung Cancer Treatment

During the opening plenary session at the 2024 Asia Conference on Lung Cancer, experts offered their perspectives on clinical trials, combination therapies, and research initiatives. Read more


BR.31 Trial Falls Short of DFS Primary Endpoint

Haleigh Behrman
on: December 17, 2024In: Meeting News, Society News
BR.31 Trial Falls Short of DFS Primary Endpoint

Prof. Glenwood Goss said adjuvant durvalumab did not improve disease-free survival outcomes following complete resection and optional chemotherapy. Read more

IASLC Lectureships Honor the Work of Thoracic Oncology Trailblazers

Haleigh Behrman
on: December 17, 2024In: Meeting News, Society News, WCLC News
IASLC Lectureships Honor the Work of Thoracic Oncology Trailblazers

Nine difference-makers in the field of lung cancer shared their groundbreaking work during the IASLC Lectureship Awards presentations at WCLC 2024. Read more

Zidesamtinib Demonstrates Promising Response in ROS1-Positive NSCLC

Haleigh Behrman
on: December 03, 2024In: Evolving Standards of Care, Meeting News, Society News
Zidesamtinib Demonstrates Promising Response in ROS1-Positive NSCLC

Prof. Benjamin Besse said the TKI showed encouraging clinical activity in patients who were heavily pre-treated. Read more

Novel ALK-Selective TKI Looks Promising Based on Findings From ALKOVE-1 Trial

Haleigh Behrman
on: December 03, 2024In: Evolving Standards of Care, Meeting News, Society News
Novel ALK-Selective TKI Looks Promising Based on Findings From ALKOVE-1 Trial

Dr. Alexander Drilon said most patients with ALK-positive NSCLC treated with NVL-655 showed disease regression and deep responses. Read more

Older Age Alone Does Not Preclude Benefit From Early Detection

Krithika Subramanian, PhD
on: December 03, 2024In: Meeting News, Screening/ED, Society News
Older Age Alone Does Not Preclude Benefit From Early Detection

Dr. Matt Warkentin says in those without significant comorbidity and who are fit for surgery, screening may provide survival benefits. Read more

Burden of Lung Cancer Care and Treatment Takes a Toll Beyond Pocketbooks

Krithika Subramanian, PhD
on: December 03, 2024In: Meeting News, Patient Advocacy, Society News
Burden of Lung Cancer Care and Treatment Takes a Toll Beyond Pocketbooks

Dr. Katie Smith says pragmatic clinical trials reveal the impact of symptom burden in young patients. Read more

Positive Impact of Asbestos Bans on Burden of Asbestos-Related Lung Cancer May Take Several Decades

Krithika Subramanian, PhD
on: December 03, 2024In: Global Initiatives, Meeting News, Risk Assessment and Reduction, Society News
Positive Impact of Asbestos Bans on Burden of Asbestos-Related Lung Cancer May Take Several Decades

Dr. Li said a considerable global burden of asbestos-related lung cancers and mesothelioma persists, even as beneficial impact of national asbestos bans are awaited. Read more

Combining Inflammatory Pathway Modulators and Immune Cell Activators with Immunotherapy May Improve or Rescue Responsiveness

Krithika Subramanian, PhD
on: November 26, 2024In: Meeting News, WCLC News
Combining Inflammatory Pathway Modulators and Immune Cell Activators with Immunotherapy May Improve or Rescue Responsiveness

Experts, including Dr. Melina E. Marmarelis, revealed different approaches to overcoming resistance to immune checkpoint inhibitors. Read more

Breakthroughs in Targeting KRAS G12C Mutations in NSCLC

Krithika Subramanian, PhD
on: November 26, 2024In: Meeting News, WCLC News
Breakthroughs in Targeting KRAS G12C Mutations in NSCLC

Dr. Ziming Li and other panelists recently explored encouraging clinical trial data for novel therapies, including garsorasib, olomorasib, fulzerasib, and divarasib. Read more

‹123456›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy